Navigation Links
What About Us? The State of Women's Sexual Health in Question
Date:1/6/2011

SADDLE BROOK, N.J., Jan. 6, 2011 /PRNewswire/ -- The FDA's nod to a new testosterone gel for men will expand the options they have to address the problems of sexual dysfunction. "So where does this leave women?" asks Rachel Braun Scherl, president of Semprae Laboratories, Inc. The announcement of the approval of Fortesta comes just months after the FDA's unanimous rejection of Flibanserin. Dubbed the "pink pill," the female Viagra equivalent, many thought it would be the game changer in closing the gender gap among the sexes.

While Braun Scherl maintains that she credits the men's sexual enhancement category in heightening overall awareness of sexual health, she believes the time has come for culture and network executives to acknowledge women's sexuality.

"Women's sexual well-being is equally important, and they are entitled to sexual pleasure.  Close to half of all women report some form of sexual concern, according to statistics from the American Medical Association," she says.

Yet, decades after the introduction of Viagra and Cialis, she maintains, women still don't have as many options...and culture and advertisers lag behind in giving women's sexual satisfaction the same level of acceptance as men's sexual needs.

Braun Scherl and her business partner, CEO Mary Wallace Jaensch, market Zestra® Essential Arousal Oils™, a clinically proven, hormone-free breakthrough for women documented in two peer reviewed, published studies to boost women's libido,  increase arousal and improve overall satisfaction.  While many health professionals enthusiastically recommend it for patients with dulled desire, advertisers have been reluctant to accept commercials for this topically applied, safe and effective gel.  If they do agree to air Zestra commercials, airtime is often restricted to limited early morning hours.

Meantime, maintains Wallace Jaensch, TV spots for men's sexual erectile dysfunction products are aired on the networks during all hours of the day.  With decreased libido and sexual dissatisfaction so pervasive in women at all stages of their reproductive life, she adds, "It's time women know there are ways they can effectively combat their loss of libido and have great sex effortlessly.  Giving women more options, expanded access to information about these options, and encouraging them to discuss their sexuality openly, are important in closing the sexual satisfaction gap that remains," says Wallace Jaensch.    


'/>"/>
SOURCE Semprae Laboratories, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Use it or Lose it: A New Theory About Preserving Erectile Function After Prostate Surgery
2. Bonnie Blair to Break the Ice About Stress Urinary Incontinence in Milwaukee
3. Second Thoughts about Fluoride, Reports Scientific American
4. Mayo Clinic Proceedings Contributors Highlight Research Findings About Cardiovascular Benefits Associated With Omega-3 Fatty Acids
5. The Anatomy of Clinical Trials: Greys Season Finale Leaves Public in the Dark About the Myths and Realities
6. About 60 Clinical Studies Regarding Schering-Ploughs Oncology Compounds Will be Presented at ASCO
7. Controversy About Lack of Placebo Group Decline in Alzheimers Clinical Trials
8. Joint Commission Urges Patients to Speak Up About Pain
9. ASGE Encourages Patients to Speak to Their Doctor About Colorectal Cancer Screening Options
10. ASGE and The Pancreatic Cancer Action Network Partner to Raise Awareness About Pancreatic Cancer
11. Perceptive Informatics Introduces Medical Imaging Methodology to Accelerate Development Decisions About Alzheimers Treatments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... , April 28, 2016 Oramed Pharmaceuticals ... clinical-stage pharmaceutical company focused on the development of oral drug ... the upcoming PIONEERS 2016 conference, presented by Joseph Gunnar ... in New York . Nadav Kidron ... the conference. Presentation Details:   ...
(Date:4/28/2016)... New market research titled ... report that provides an overview of the Osteoarthritis,s ... identifying new targets and MOAs to produce first-in-class ... in this H1 2016 Osteoarthritis Pipeline report include ... Abiogen Pharma S.p.A., Ablynx NV, Achelios Therapeutics, Inc., ...
(Date:4/27/2016)... , April 27, 2016   ... 42% Growth in Recurring Consumable Sales  Clinical ... Mauna Kea Technologies (Euronext: MKEA, OTCQX: MKEAY) inventor of ... its sales for the first quarter ended March 31, ... the execution of its commercial strategy. First ...
Breaking Medicine Technology:
(Date:4/29/2016)... ... ... On Tuesday, April 26, 2016 members of the HomeTown Health network, a ... Deal on SB 258, the “Rural Health Care Relief” Bill. , The bill, which ... to individuals and corporations which donate directly to a “rural hospital” in Georgia, and ...
(Date:4/29/2016)... ... April 29, 2016 , ... The White House ... their loans, more information about their loan terms and accounts, and more protections ... debt, including federal and private loans, has reached $1.3 trillion, with 43 million ...
(Date:4/29/2016)... ... April 29, 2016 , ... A ... born with severe congenital diaphragmatic hernia have better survival rates if surgery is ... hernia (CDH)—a condition where the diaphragm fails to form completely, letting abdominal organs ...
(Date:4/29/2016)... ... 2016 , ... Mobility Designed is redefining mobility with their patent pending ... Crutch evenly distributes body weight from the elbow to the forearm. In consumer ... than with other crutches. , Co-founders Max and Liliana Younger were inspired to design ...
(Date:4/29/2016)... (PRWEB) , ... April 29, 2016 , ... Melanoma is the deadliest type of skin ... blame for the majority of skin cancer deaths. More than 10,000 people are expected to ... at diagnosis is 62, it is the one of the most commonly diagnosed cancers in ...
Breaking Medicine News(10 mins):